18F-MK-6240: Clinical Trials

5 trials of 18F-MK-6240, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed, 1 recruiting, 1 terminated. 2 Phase 2, 1 Early Phase 1, 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 22Completed 2
Early Phase 11Terminated 1
Phase 11Completed 1

Follow 18F-MK-6240: new trials by email Literature Review of 18F-MK-6240 trials Research Report on 18F-MK-6240

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Transcranial Photobiomodulation for Alzheimer's Disease (TRAP-AD)
Active tPBM-2.0, Sham tPBM-2.0, 18F-MK-6240 - Mild Cognitive Impairment, Alzheimer Disease
Phase 2CompletedNYU Langone Health1962021-04-272026-10-29
Brain Imaging in the Diabetes Prevention Program Outcomes Study
18F-MK-6240, 11C-PIB - Alzheimer Disease
Early Phase 1TerminatedJosé A. Luchsinger52019-10-012024-03-04
Alzheimer's PET Imaging in Racially/Ethnically Diverse Adults
18F-MK-6240, 18F-Florbetaben - Alzheimer Disease
Phase 1CompletedAdam Brickman1452019-03-222025-08-01
Tau PET in Imaging and Cognition: Healthy Adults From 55-90
18F-MK-6240 - Mild Cognitive Impairment, Aging
RecruitingYaakov Stern1052018-06-012026-02-11
Imaging Tau in Alzheimer's Disease and Normal Aging
18F-MK-6240, Lumbar Puncture (optional) - Alzheimer Disease
Phase 2CompletedPatrick Lao712017-12-112025-05-08

Conditions studied

Alzheimer Disease (4)  ·  Cognitive Dysfunction (3)  ·  Pick Disease of the Brain (2)  ·  Diabetes Mellitus, Type 2 (1)  ·  Glucose Intolerance (1)

Sponsors

Adam Brickman (1)  ·  José A. Luchsinger (1)  ·  NYU Langone Health (1)  ·  Patrick Lao (1)  ·  Yaakov Stern (1)

Countries

United States (5)

Top investigators

Adam M. Brickman, Ph.D. (1)  ·  Dan Iosifescu, MD (1)  ·  Jose A. Luchsinger, MD (1)  ·  Paolo Cassano, MD, PhD (1)  ·  Patrick Lao, PhD (1)  ·  Ricardo Osorio, MD (1)  ·  Yaakov Stern, PhD (1)

Results publications

PMID 33646153

NIH funding

1RF1AG058067-01A1 (1), 2RF1AG038465-06 (1), K23AG052633 (1), K24AG045334 (1), R01AG050440 (1), R01AG055299 (1), R56AG034189 (1), U01DK048404 (1)